On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Home > You searched for INMB > Page 4

Search Results for: INMB

INmune Bio Inc. (NASDAQ: INMB) is “One to Watch”

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation … Continue reading “INmune Bio Inc. (NASDAQ: INMB) is “One to Watch””

QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at Ninth Annual LD Micro Invitational on June 5

INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that its co-founder and CFO David Moss will present at the Ninth Annual LD Micro Invitational. The event will be held on June 4 to 5, 2019 at the Luxe Sunset Boulevard … Continue reading “QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at Ninth Annual LD Micro Invitational on June 5”

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .